CRGX Valuation

CARGO Therapeutics Inc

Add to Watchlist

Advanced Chart

0.000

-4.47(-100.000%)1D

Overview
Forecast
Valuation
Earnings

CRGX Relative Valuation

CRGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRGX is overvalued; if below, it's undervalued.

Historical Valuation

CARGO Therapeutics Inc (CRGX) is now in the Fair zone, suggesting that its current forward PS ratio of 73.19 is considered Fairly compared with the five-year average of -3.46. The fair price of CARGO Therapeutics Inc (CRGX) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：4.51

Fair

-1.89

Trailing

Forward

0.23

EV/EBITDA

CARGO Therapeutics Inc. (CRGX) has a current EV/EBITDA of 0.23. The 5-year average EV/EBITDA is -1.48. The thresholds are as follows: Strongly Undervalued below -5.36, Undervalued between -5.36 and -3.42, Fairly Valued between 0.47 and -3.42, Overvalued between 0.47 and 2.41, and Strongly Overvalued above 2.41. The current Forward EV/EBITDA of 0.23 falls within the Historic Trend Line -Fairly Valued range.

0.26

EV/EBIT

CARGO Therapeutics Inc. (CRGX) has a current EV/EBIT of 0.26. The 5-year average EV/EBIT is -1.57. The thresholds are as follows: Strongly Undervalued below -5.64, Undervalued between -5.64 and -3.60, Fairly Valued between 0.46 and -3.60, Overvalued between 0.46 and 2.49, and Strongly Overvalued above 2.49. The current Forward EV/EBIT of 0.26 falls within the Historic Trend Line -Fairly Valued range.

73.19

CARGO Therapeutics Inc. (CRGX) has a current PS of 73.19. The 5-year average PS is 19.18. The thresholds are as follows: Strongly Undervalued below -66.96, Undervalued between -66.96 and -23.89, Fairly Valued between 62.26 and -23.89, Overvalued between 62.26 and 105.33, and Strongly Overvalued above 105.33. The current Forward PS of 73.19 falls within the Overvalued range.

6.87

P/OCF

CARGO Therapeutics Inc. (CRGX) has a current P/OCF of 6.87. The 5-year average P/OCF is -3.28. The thresholds are as follows: Strongly Undervalued below -8.76, Undervalued between -8.76 and -6.02, Fairly Valued between -0.55 and -6.02, Overvalued between -0.55 and 2.19, and Strongly Overvalued above 2.19. The current Forward P/OCF of 6.87 falls within the Strongly Overvalued range.

-1.72

P/FCF

CARGO Therapeutics Inc. (CRGX) has a current P/FCF of -1.72. The 5-year average P/FCF is -3.37. The thresholds are as follows: Strongly Undervalued below -5.89, Undervalued between -5.89 and -4.63, Fairly Valued between -2.10 and -4.63, Overvalued between -2.10 and -0.84, and Strongly Overvalued above -0.84. The current Forward P/FCF of -1.72 falls within the Overvalued range.

CARGO Therapeutics Inc (CRGX) has a current Price-to-Book (P/B) ratio of 0.89. Compared to its 3-year average P/B ratio of 1.43 , the current P/B ratio is approximately -37.84% higher. Relative to its 5-year average P/B ratio of 1.43, the current P/B ratio is about -37.84% higher. CARGO Therapeutics Inc (CRGX) has a Forward Free Cash Flow (FCF) yield of approximately -87.34%. Compared to its 3-year average FCF yield of -33.75%, the current FCF yield is approximately 158.78% lower. Relative to its 5-year average FCF yield of -33.75% , the current FCF yield is about 158.78% lower.

0.89

P/B

Median3y

1.43

Median5y

1.43

-87.34

FCF Yield

Median3y

-33.75

Median5y

-33.75

Competitors Valuation Multiple

The average P/S ratio for CRGX's competitors is 17.07, providing a benchmark for relative valuation. CARGO Therapeutics Inc Corp (CRGX) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

CRGX.O

CARGO Therapeutics Inc

Monopar Therapeutics Inc

Loss

209.93M

TVRD.O

Tvardi Therapeutics Inc

Galectin Therapeutics Inc

Loss

271.94M

CTNM.O

Contineum Therapeutics Inc

46.78

294.16M

Performance Decomposition

Market capitalization of CRGX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of CRGX in the past 1 year is driven by Unknown.